{"database": "lobbying", "table": "lobbying_activities", "rows": [[3046355, "71dfa007-514d-4ff6-9c84-4d6ff303baf6", "Q3", "F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES", 18411, "F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES", 2023, "third_quarter", "MMM", "(MMM) Clinical Lab Fee Schedule H.R. 2377 and S. 1000. Saving Access to Laboratory Services Act (SALSA), and HR 1691 Ensuring Patient Access to Critical Breakthrough Products Act of 2023", "HOUSE OF REPRESENTATIVES,SENATE", null, 120000, 0, 0, "2023-10-09T14:02:54-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3046355"], "units": {}, "query_ms": 18.390002893283963, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}